| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Dec 12, 2018 | 97.12 | 97.30 | 78.36 | 91.34 | 10,539,636 |
| Dec 11, 2018 | 77.60 | 85.44 | 76.42 | 84.80 | 7,070,122 |
| Dec 10, 2018 | 81.76 | 85.42 | 75.48 | 76.54 | 4,766,787 |
| Dec 7, 2018 | 81.00 | 83.88 | 80.76 | 83.44 | 6,529,909 |
| Dec 6, 2018 | 93.50 | 93.50 | 80.06 | 82.96 | 8,023,326 |
| Name | Indivior | Epic | INDV |
|---|---|---|---|
| ISIN | GB00BRS65X63 | Currency | GBX |
| Type | Equity | Trading Segment | STMM |
| Record Status | Active | Trading Status | Regular Trading |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 5,000 | Prev Close | 91.34 |
| Shares in Issue (m) | 728.44 | Market Cap (£m) | 665.36 |
| PE Ratio | 11.42 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | 8.00 | EPS Growth (%) | 60.00 |
| PEG | 0.19 | DPS Growth (%) | n/a |
| ROCE | 23.22 | Net Gearing | 54.29 |
| Quick Ratio | 1.37 | Current Ratio | 1.43 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 12 Dec | RBC Capital Markets | Sector Performer | 93.79 | 130.00 | - | Downgrades |
| 21 Nov | RBC Capital Markets | Outperform | 93.79 | 350.00 | 130.00 | Downgrades |
| 15 Oct | Citigroup | Neutral | 93.79 | 240.00 | - | Reiterates |
| 11 Oct | Jefferies International | Buy | 93.79 | 250.00 | 245.00 | Reiterates |
| 27 Sep | Numis | Buy | 93.79 | 350.00 | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 13 Mar 2018 | Shaun Thaxter | Transfer In | 1,219,432 @ 0.00p | £0.00 |
| 13 Mar 2018 | Shaun Thaxter | Sell | 551,896 @ 403.64p | £2,227,673.01 |
| 28 Feb 2018 | Mark Crossley | Transfer In | 288,345 @ 0.00p | £0.00 |
| 28 Feb 2018 | Mark Crossley | Sell | 130,501 @ 379.00p | £494,598.79 |
| 27 Feb 2017 | Howard Pien | Buy | 9,688 @ 341.60p | £33,094.21 |
